Form 4 holding
Director
Telomir Pharmaceuticals, Inc.
- Security class
- Incentive Stock Options (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 21 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount